Answers are grounded in this paper and cite their sources.
Pharmaceutical active compounds (PhACs) are emerging contaminants in aquatic environments due to their extensive use and persistence, posing ecological risks and potential threats to human health. Conventional wastewater treatment plants often fail to completely remove these micropollutants, necessitating advanced treatment technologies. Electrochemical oxidation (EO) has gained significant attention as a sustainable and effective tertiary treatment for degradation of PhACs due to its operational simplicity, minimal chemical addition, and potential for complete mineralization. Recent advancements in anode materials−including boron-doped diamond (BDD), dimensionally stable anodes (DSA), and novel nanostructured electrodes−have enhanced oxidation kinetics and broadened the spectrum of treatable compounds. Coupling EO with auxiliary processes such as photoelectrochemical oxidation, sonoelectrochemical treatment, and membrane filtration demonstrates further improvements in removal efficiency and energy performance. Current research trends also focus on understanding reaction mechanisms, identifying transformation products, optimizing energy consumption, and scaling up reactor designs for real-world applications. Despite challenges related to cost, electrode fouling, and by-product formation, EO represents a promising technology for mitigating PhAC contamination in wastewater streams. This paper reviews the state-of-the-art developments, practical limitations, and future directions for EO as a key strategy toward sustainable pharmaceutical removal in water treatment.
No takes yet. Share an insight, caveat, or question.
Sharma et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: